Fig. 2
From: LARGE expression in different types of muscular dystrophies other than dystroglycanopathy
Illustrative images of muscle sections with hematoxylin and eosin staining (left-hand panel; scale bars: 40 μm.), glycosylated αDG labeling with VIA4–1 antibody (middle panel; scale bars: P1, P17 and P23: 20 μm.; P2: 40 μm.) and α-DG core antibody (right-hand panel; scale bars: 40 μm.). αDG labeling was normal in merosin deficiency (P17), mildly reduced in CMD (P23), but severely reduced/absent in cases with dystrophin deficiency (P1 and P2). Expression of the core αDG protein was well preserved in all samples